• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Renin: friend or foe?肾素:是友还是敌?
Heart. 2007 Sep;93(9):1026-33. doi: 10.1136/hrt.2006.107706. Epub 2007 May 8.
2
The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure.血浆肾素试验揭示了机体钠容量含量(V)和肾素-血管紧张素(R)血管收缩对长期血压的影响。
Am J Hypertens. 2011 Nov;24(11):1164-80. doi: 10.1038/ajh.2011.171. Epub 2011 Sep 22.
3
Renin inhibition in hypertension.高血压中的肾素抑制作用。
J Am Coll Cardiol. 2008 Feb 5;51(5):519-28. doi: 10.1016/j.jacc.2007.10.027.
4
[The future of renin inhibition].[肾素抑制的未来]
Turk Kardiyol Dern Ars. 2009 Oct;37 Suppl 7:32-8.
5
Clinical role of direct renin inhibition in hypertension.直接肾素抑制在高血压中的临床作用。
Am J Ther. 2012 May;19(3):204-10. doi: 10.1097/MJT.0b013e3182068da5.
6
Recent changes in the landscape of combination RAS blockade.联合RAS阻断领域的近期变化。
Expert Rev Cardiovasc Ther. 2009 Nov;7(11):1373-84. doi: 10.1586/erc.09.127.
7
Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.阿利吉仑对健康人体直接抑制肾素的肾脏和激素反应。
Circulation. 2008 Jun 24;117(25):3199-205. doi: 10.1161/CIRCULATIONAHA.108.767202. Epub 2008 Jun 16.
8
Inhibition of renin: an updated review of the development of renin inhibitors.肾素抑制:肾素抑制剂研发的最新综述
Curr Opin Investig Drugs. 2007 Sep;8(9):750-7.
9
Therapeutic approaches in lowering albuminuria: travels along the renin-angiotensin-aldosterone-system pathway.降低蛋白尿的治疗方法:沿着肾素-血管紧张素-醛固酮系统途径探索。
Adv Chronic Kidney Dis. 2011 Jul;18(4):290-9. doi: 10.1053/j.ackd.2011.04.001.
10
[What is renin inhibition? Mechanism of action].[什么是肾素抑制?作用机制]
Turk Kardiyol Dern Ars. 2009 Oct;37 Suppl 7:5-14.

引用本文的文献

1
Empagliflozin and fluid balance: results from the SiRENA project.恩格列净与液体平衡:SiRENA项目的结果
Clin Kidney J. 2025 Aug 15;18(9):sfaf262. doi: 10.1093/ckj/sfaf262. eCollection 2025 Sep.
2
Blood pressure response to mineralocorticoid receptor antagonists or aldosterone synthase inhibitors according to baseline renin levels.根据基线肾素水平,血压对盐皮质激素受体拮抗剂或醛固酮合酶抑制剂的反应。
J Hum Hypertens. 2025 May 3. doi: 10.1038/s41371-025-01021-9.
3
Comparative effects of angiotensin II stimulating and inhibiting antihypertensives on dementia risk: a systematic review and meta-analysis.血管紧张素II刺激剂和抑制剂类降压药对痴呆风险的比较效应:一项系统评价和荟萃分析
Geroscience. 2025 Apr 4. doi: 10.1007/s11357-025-01600-1.
4
Novel pharmacological approaches to lowering blood pressure and managing hypertension.降低血压和控制高血压的新型药理学方法。
Nat Rev Cardiol. 2025 Feb 7. doi: 10.1038/s41569-025-01131-4.
5
The Renin-Angiotensin System and Cardiovascular-Kidney-Metabolic Syndrome: Focus on Early-Life Programming.肾素-血管紧张素系统与心血管-肾脏-代谢综合征:关注生命早期编程。
Int J Mol Sci. 2024 Mar 14;25(6):3298. doi: 10.3390/ijms25063298.
6
Delayed Graft Function and the Renin-angiotensin System.移植肾功能延迟恢复与肾素-血管紧张素系统
Transplantation. 2024 Jun 1;108(6):1308-1318. doi: 10.1097/TP.0000000000004934. Epub 2024 Feb 16.
7
Renin Trajectories and Outcome in Stable Heart Failure with Reduced Ejection Fraction (HFrEF) on Contemporary Therapy: A Monocentric Study from an Austrian Tertiary Hospital Outpatient Clinic.当代治疗下射血分数降低的稳定心力衰竭(HFrEF)中肾素轨迹与结局:来自奥地利一家三级医院门诊的单中心研究。
J Renin Angiotensin Aldosterone Syst. 2023 Oct 31;2023:8883145. doi: 10.1155/2023/8883145. eCollection 2023.
8
Response surface analyses of antihypertensive effects of angiotensin receptor blockers and amlodipine or hydrochlorothiazide combination therapy in patients with essential hypertension.血管紧张素受体阻滞剂与氨氯地平或氢氯噻嗪联合治疗原发性高血压患者降压效果的响应面分析
Transl Clin Pharmacol. 2023 Sep;31(3):154-166. doi: 10.12793/tcp.2023.31.e15. Epub 2023 Sep 19.
9
Time to eRAASe chronic inflammation: current advances and future perspectives on renin-angiotensin-aldosterone-system and chronic intestinal inflammation in dogs and humans.是时候消除慢性炎症了:犬类和人类肾素-血管紧张素-醛固酮系统与慢性肠道炎症的当前进展及未来展望
Front Vet Sci. 2023 Jun 29;10:1180125. doi: 10.3389/fvets.2023.1180125. eCollection 2023.
10
ER ribosomal-binding protein 1 regulates blood pressure and potassium homeostasis by modulating intracellular renin trafficking.内质网核糖体结合蛋白 1 通过调节细胞内肾素运输来调节血压和钾离子稳态。
J Biomed Sci. 2023 Feb 19;30(1):13. doi: 10.1186/s12929-023-00905-7.

本文引用的文献

1
The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.螺内酯、氨氯吡咪、氯沙坦与噻嗪类药物(SALT)对低肾素性高血压和醛固酮-肾素比值升高患者的双盲交叉试验。
Circulation. 2007 Jul 17;116(3):268-75. doi: 10.1161/CIRCULATIONAHA.107.690396. Epub 2007 Jul 2.
2
Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system.抑制肾素-血管紧张素系统药物的血压依赖性及非依赖性作用
J Hypertens. 2007 May;25(5):951-8. doi: 10.1097/HJH.0b013e3280bad9b4.
3
Multiple biomarkers for the prediction of first major cardiovascular events and death.用于预测首次重大心血管事件和死亡的多种生物标志物。
N Engl J Med. 2006 Dec 21;355(25):2631-9. doi: 10.1056/NEJMoa055373.
4
Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.阿利吉仑与噻嗪类利尿剂、血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂联合使用时,可降低血压并抑制血浆肾素活性。
Hypertension. 2007 Feb;49(2):276-84. doi: 10.1161/01.HYP.0000253780.36691.4f. Epub 2006 Dec 11.
5
Oral renin inhibitors.口服肾素抑制剂
Lancet. 2006 Oct 21;368(9545):1449-56. doi: 10.1016/S0140-6736(06)69442-7.
6
Hypertension and ethnic group.高血压与种族群体。
BMJ. 2006 Apr 8;332(7545):833-6. doi: 10.1136/bmj.332.7545.833.
7
Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension.肾素原的非蛋白水解激活促进遗传性高血压中心脏纤维化的发展。
Hypertension. 2006 May;47(5):894-900. doi: 10.1161/01.HYP.0000215838.48170.0b. Epub 2006 Apr 3.
8
Renoprotective effects of renin-angiotensin-system inhibitors.
Lancet. 2006 Mar 18;367(9514):898-9; author reply 900-2. doi: 10.1016/S0140-6736(06)68373-6.
9
Renin inhibition with aliskiren: where are we now, and where are we going?阿利吉仑对肾素的抑制作用:我们目前的状况如何,又将走向何方?
J Hypertens. 2006 Feb;24(2):243-56. doi: 10.1097/01.hjh.0000202812.72341.99.
10
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.降压药物对中心动脉压及临床结局的不同影响:导管动脉功能评估(CAFE)研究的主要结果
Circulation. 2006 Mar 7;113(9):1213-25. doi: 10.1161/CIRCULATIONAHA.105.595496. Epub 2006 Feb 13.

肾素:是友还是敌?

Renin: friend or foe?

作者信息

Brown Morris J

机构信息

Clinical Pharmacology Unit, Addenbrookes Hospital, Cambridge, UK.

出版信息

Heart. 2007 Sep;93(9):1026-33. doi: 10.1136/hrt.2006.107706. Epub 2007 May 8.

DOI:10.1136/hrt.2006.107706
PMID:17488768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1955008/
Abstract

Renin maintains blood pressure through vasoconstriction when there is inadequate salt to maintain volume. In populations where blood pressure is more often high than low, and vascular death more common than haemorrhage or dehydration, therapeutic reductions in renin secretion or response are valuable. Whether long-term benefits are due entirely to blood pressure reduction remains unproved. The pathway can be blocked at its rate-limiting step (beta blockade or direct renin inhibition), the synthesis of the active product, angiotensin II, or at the receptor for angiotensin. Because renin and sodium are the two main factors in blood pressure control, and renin levels vary inversely with sodium load, blood pressure control requires a combination of natriuresis and blocking the consequential increase in renin activity. Being a large and stable molecule, renin is among the easiest and cheapest of hormone measurements. Understanding the simple biochemistry and physiology of renin permits optimal use of the drugs acting to raise or suppress this hormone.

摘要

当体内盐分不足以维持血容量时,肾素通过血管收缩来维持血压。在血压偏高而非偏低、血管性死亡比出血或脱水更常见的人群中,治疗性降低肾素分泌或反应具有重要价值。肾素分泌或反应的长期益处是否完全归因于血压降低,这一点仍未得到证实。该途径可以在其限速步骤(β受体阻滞剂或直接肾素抑制)、活性产物血管紧张素II的合成或血管紧张素受体处被阻断。由于肾素和钠是控制血压的两个主要因素,且肾素水平与钠负荷呈负相关,因此血压控制需要利钠作用与阻断肾素活性随之增加两者相结合。肾素是一种大分子且稳定的物质,是最容易且最便宜检测的激素之一。了解肾素简单的生物化学和生理学知识,有助于优化使用作用于升高或抑制这种激素的药物。